Universal Ibogaine Co-Founder Dr Alberto Sola has administered over 3700 ibogaine detox treatments, more than any other doctor in the world.
The business is happy to announce that PreCerv Inc. ("PreCerv") has been incorporated as a completely owned subsidiary. A worldwide field of use licence for NCP-01 and its autologous stem cell technology will be acquired by PreCerv from Hemostemix.
"We are happy to have access to Blue Digital's distribution channels, as their range across borders will broaden awareness of our business to new audiences," said Nick Karos, UI's Chief Executive Officer. Because addiction knows no bounds, the remedy we seek must be global in scope." As Blue Digital Media professional radar.
$HMTXF today marked quite an impressive opening in the otc market and is currently trading with a steady pace at $0.1960 with a notable spike Hemostemix hires new financial advisor to the family Mr. Rick Groome who has effectively settled 2 securities firm, helping many successful biotechnology companies in providing funds over the last three decades has...
Julie Dumouchel has been named Director of Clinical Trials at UI, which is a significant strategic move. Julie Dumouchel has 25 years of experience in the pharmaceutical sector, where she has worked in a variety of clinical research jobs and has a thorough grasp of the drug development process.
Universal Ibogaine Inc. is an expanding Canadian-holding company with an average volume of 138 K+ in the last 50 days . The average volume of the company in the last 10 days is $88.98K with $190.74M share outstanding. The stock price when the market opened was $0.05
"H.C. Wainwright is a leader in the field and may be a significant strategic partner in our ongoing corporate finance roadmap," said Nick Karos, CEO of Universal Ibogaine. Another crucial step in raising awareness of our brand and service is the chance to share our story with this audience.
Excellence and IBO always go hand in hand when it comes to proving its potential in the market and leaving competitors way behind the bar. The shares are trading live at $0.05 with a significant spike
With the current buyout price of $0.095, the company has around 6.5 million+ market cap, proliferating exponentially. Add the life science-based stock in your watch list and boost your portfolio.
Trend line breakout Add qty above 36.50 support 34.70 Stock P/E 4.15 Book Value ₹ 72.3 healthy dividend payout of 32.02% dividend yield of 6.11%.
#MONDAY> <#SHORT-TERM> NSE:RENUKA { Why SHREE RENUKA ??? VOLUME during this month is comparatively higher than past 4-5 years volume...(On Monthly candles); its net profit has been increased drastically from quarters to quarters; good news is being seen sugar industries; it's earnings is going to be announced next month (May 28); Be careful It's a PENNY...
buying idea on paramount communication for holding purpose taking support over 200 days moving average good name in optical fiber fundamentally still a good company good to have in portfolio for future prospect
After making of H and S pattern a massive downfall is scene in the stock as can sustain below given levels it can show trend reversal .Currently stock is sustaining by support of 200 MA on daily chart.
IMP POWERS LTD 1) Wait for the Resistance breakout 2) Can expect minimum 20 to 30 % upside move 3) Target levels are mentioned in the chart
#gokulrefoils Gokul refoils looks good on charts with Weekly close sl of 33. Ckt stock, so be careful and know the risk. #vr
invest with caution, always consult your financial advisor before taking any investment, this is not a investment advice this is just my view for educational purposes. Keep trailing SL if this goes up, maintain a SL of 22-25 percent
good gains of 70% possible this is for only educational purpose so only Khatro ke Khiladi try this and enjoy your profits